Form 4: Humana Director Jorge S. Mesquita Acquires Restricted Stock Units

Humana director Jorge S. Mesquita acquired 783 restricted stock units on January 2, 2025, representing a contingent right to receive common stock.

Summary

• Jorge S. Mesquita, a director at Humana Inc., acquired 783 restricted stock units on January 2, 2025.
• These restricted stock units represent a contingent right to receive one share of Humana common stock each.
• The acquisition was made under the company's 2019 Amended & Restated Plan and is exempt under Rule 16b-3(d)(1)&(3).
• Following the transaction, Mr. Mesquita beneficially owns 3,361 shares of Humana common stock indirectly through a revocable trust where he is the sole trustee.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with shareholders.

Positives

• The acquisition of restricted stock units by a director may indicate confidence in the company's future performance.

Industry Context

This is a routine filing related to a director's equity compensation and is common in publicly traded companies.

Comparison to Industry Standards

• Equity compensation in the form of restricted stock units is a common practice for directors in publicly traded companies like Humana.
• The number of units granted is not unusual for a director's compensation package.
• Similar filings are regularly made by directors and officers of comparable companies such as UnitedHealth Group and CVS Health.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.

Key Dates

Keywords

Humana, Director, Restricted Stock Units, Beneficial Ownership, Form 4, Equity Securities, Jorge S. Mesquita